ENDRA Life Sciences Inc. filed a Registration Statement for an underwritten public offering of common stock and warrants, including preliminary estimated financial results for the fiscal quarter ended March 31, 2023.
AI Assistant
ENDRA LIFE SCIENCES INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.